数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

   NURO
-- -- --

今开：-- 昨收：-- 最高：-- 最低：--
成交量：--万手 市盈率：-- 总市值($)：-- 换手率：--
加入自选股

首页概览 公司概况 财务分析 高管介绍 股本结构 公司新闻

股本结构

单位：万股
公告日期 2024-03-01 2024-03-01 2023-11-20 2023-10-26 2023-09-11 2023-07-27
证券总股本 198.65 152.49 109.17 859.14 858.50 857.95
普通股本 198.65 152.49 109.17 859.14 858.50 857.95
优先股 未披露 0.02 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2024-02-29 2023-12-31 2023-11-22 2023-10-25 2023-08-31 2023-07-26
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2024-03-01 198.65 未披露 定期报告 2024-02-29
2024-03-01 152.49 0.02
更多>>
From December 31,2022 to December 31,2023 Issuance of common stock under at the market offering Issuance of common stock under employee stock purchase plan Vesting of restricted stock under equity plan
2023-12-31
2023-11-20 109.17 未披露
更多>>
NeuroMetrix, Inc. announced that it will effect a one-for-eight reverse split of its common stock, effective at 5:00 pm on November 21, 2023 (the “Effective Time”).
2023-11-22
2023-10-26 859.14 未披露 定期报告 2023-10-25
2023-09-11 858.50 未披露 定期报告 2023-08-31
2023-07-27 857.95 未披露 定期报告 2023-07-26
2023-05-03 783.95 未披露 定期报告 2023-05-02
2023-05-03 778.12 未披露
更多>>
From December 31, 2022 to March 31, 2023 Vesting of restricted stock under option plan
2023-03-31
2023-03-30 779.15 未披露 定期报告 2023-03-01
2023-03-22 778.58 未披露
更多>>
From December 31, 2021 to December 31, 2022 Issuance of common stock under employee stock purchase plan Issuance of common stock under at the market offering Issuance of common stock to settle compensation obligation Vesting of restricted stock under option plan
2022-12-31
2022-10-20 775.72 未披露 定期报告 2022-10-19
2022-10-20 713.75 未披露
更多>>
From June 30, 2022 to September 30, 2022 Vesting of restricted stock under equity plan
2022-09-30
2022-07-21 713.05 未披露 定期报告 2022-07-20
2022-07-21 713.37 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock under employee stock purchase plan Issuance of common stock to settle compensation obligation Vesting of restricted stock under equity plan
2022-06-30
2022-04-26 713.01 未披露 定期报告 2022-04-25
2022-04-26 700.61 未披露
更多>>
From December 31, 2021 to March 31, 2022 Issuance of common stock under at the market offering Vesting of restricted stock under option plan
2022-03-31
2022-01-28 699.22 未披露 定期报告 2022-01-27
2022-01-28 668.05 0.02
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock under at the market offering Issuance of common stock upon exercise of stock options Issuance of common stock under employee stock purchase plan Vesting of restricted stock under option plan
2021-12-31
2021-10-22 667.54 未披露 定期报告 2021-10-21
2021-10-21 664.54 未披露
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common stock under at the market offering Issuance of common stock upon exercise of stock options Vesting of restricted stock under option plan
2021-09-30
2021-07-22 562.89 未披露 定期报告 2021-07-22
2021-07-22 504.62 未披露
更多>>
From March 31, 2021 to June 30, 2021 Issuance of common stock under at the market offering Issuance of common stock under employee stock purchase plan Vesting of restricted stock under option plan
2021-06-30
2021-04-22 380.32 未披露 定期报告 2021-04-21
2021-01-29 379.61 未披露 定期报告 2021-01-27
2021-01-29 379.37 未披露
更多>>
From December 31,2019 to December 31,2020 Issuance of common stock under at the market offering Issuance of common stock to settle compensation obligations Issuance of common stock under employee stock purchase plan
2020-12-31
2020-07-23 378.47 0.02
更多>>
From March 31, 2020 to June 30, 2020 Issuance of common stock under at the market offering Issuance of common stock under employee stock purchase plan
2020-06-30
2020-04-23 273.62 未披露 定期报告 2020-04-22
2020-04-23 168.78 0.02
更多>>
From December 31, 2019 to March 31, 2020 Issuance of common stock under at the market offering Common stock issued to settle compensation obligations
2020-03-31
2020-03-16 145.22 未披露 定期报告 2020-03-02
2020-01-28 140.07 0.02
更多>>
from December 31, 2018 to December 31, 2019 Issuance of common stock upon conversion of preferred stock Issuance of common stock under employee stock purchase plan
2019-12-31
2019-11-18 97.82 未披露
更多>>
Trading of the Company's common stock on the NASDAQ Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Tuesday, November 19, 2019, under new CUSIP number 641255807. Trading of the Company's listed warrants to purchase common stock on the Nasdaq Capital Market will also continue, on a split-adjusted basis, with the opening of the markets on Tuesday, November 19, 2019 under new CUSIP number 641255211. Shares of the Company's common stock and the Company's listed warrants to purchase common stock will continue to trade under the symbols "NURO" and "NUROW". Immediately subsequent to the reverse stock split, there will be approximately 978,175 shares of the Company's common shares issued and outstanding.
2019-11-19
2019-07-18 978.18 未披露
更多>>
From December 31, 2018 To June 30, 2019 Issuance of common stock upon conversion of preferred stock Issuance of common stock under employee stock purchase plan
2019-06-30
2019-04-25 882.03 未披露 定期报告 2019-04-22
2019-04-25 831.05 未披露
更多>>
From December 31, 2018 to March 31, 2019 Issuance of common stock upon conversion of preferred stock
2019-03-31
2019-03-13 788.05 未披露 定期报告 2019-03-04
2019-01-24 768.05 未披露 定期报告 2019-01-23
2019-01-24 738.05 未披露
更多>>
From December 31, 2017 to December 31, 2018 Issuance of common stock upon conversion of preferred stock Common stock issued to settle employee incentive compensation obligations Issuance of common stock under employees stock purchase plan
2018-12-31
2018-10-17 736.50 未披露 定期报告 2018-09-30
2018-04-20 735.67 未披露 定期报告 2018-04-13
2018-02-08 714.19 未披露 定期报告 2018-02-02
2018-02-08 270.61 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of Series E preferred stock and warrants and repricing other holdings under purchase agreement Issuance of Series F preferred stock and repurchase of certain warrants under purchase agreement Issuance of common stock upon conversion of preferred stock Issuance of common stock under employees stock purchase plan Issuance of common stock in exchange for warrants
2017-12-31
2017-10-20 234.55 未披露 定期报告 2017-10-13
2017-10-20 214.55 未披露 定期报告 2017-09-30
2017-08-07 212.55 未披露 定期报告 2017-07-31
2017-07-20 186.05 未披露 定期报告 2017-07-14
2017-07-20 165.05 2.16 定期报告 2017-06-30
2017-05-11 126.85 未披露
更多>>
NeuroMetrix, Inc.today announced a one-for-eight reverse split of its common stock effective as of Thursday, May 11, 2017. The shares underlying the Company's outstanding options and warrants will also be adjusted accordingly.Trading of the Company's listed warrants to purchase common stock on the NASDAQ Capital Market will also continue, on a split-adjusted basis, with the opening of the markets on Friday, May 12, 2017, under new CUSIP number 641255195.
2017-05-12
2017-04-20 1014.77 未披露 定期报告 2017-04-19
2017-04-20 873.99 2.16 定期报告 2017-03-31
2017-03-29 843.99 未披露 定期报告 2017-03-13
2017-02-09 791.49 未披露 定期报告 2017-02-01
2017-01-27 751.49 未披露 定期报告 2017-01-13
2017-01-23 711.49 未披露 定期报告 2017-01-09
2017-02-09 669.49 1.77
更多>>
from December 31, 2015 to December 31, 2016 Issuance of Series D preferred stock and warrants and redemption of Series C preferred stock under purchase agreement Issuance of common stock upon conversion of preferred stock Issuance of common stock under employees stock purchase plan Common stock issued to settle incentive compensation obligations
2016-12-31
2016-10-20 531.83 2.01 定期报告 2016-09-30
2016-07-21 511.83 未披露 定期报告 2016-07-15
2016-07-21 491.83 2.09 定期报告 2016-06-30
2016-04-21 438.99 1.43 定期报告 2016-03-31
2016-02-12 404.98 2.08 定期报告 2016-02-01
2016-02-12 404.73 2.09
更多>>
From December 31, 2014 to December 31, 2015 Issuance of Series B preferred stock and warrants under underwritten public offering Redemption of Series A-4 preferred stock Issuance of Series C preferred stock and warrants and redemption of Series B preferred stock under purchase agreement Issuance of common stock upon conversion of preferred stock Issuance of common stock under employees stock purchase plan Common stock issued to settle incentive compensation obligations As previously disclosed on a Current Report on Form 8-K filed on December 1, 2015, we filed a Certificate of Amendment to our Restated Certificate of Incorporation to effect a 1-for-4 reverse stock split of our common stock as of December 1, 2015
2015-12-31
2016-01-08 344.63 未披露
更多>>
As previously disclosed on a Current Report on Form 8-K filed on December 1, 2015, we filed a Certificate of Amendment to our Restated Certificate of Incorporation to effect a 1-for-4 reverse stock split of our common stock as of December 1, 2015
2015-12-02
2015-10-22 1378.52 9.41 定期报告 2015-09-30
2015-09-29 1378.52 未披露 定期报告 2015-09-17
2015-07-23 1104.10 未披露 定期报告 2015-07-22
2015-07-23 1099.64 12.23 定期报告 2015-06-30
2015-04-13 851.92 0.32 定期报告 2015-03-31
2015-03-30 851.92 未披露 定期报告 2015-03-13
2015-02-25 815.27 0.36
更多>>
from December 31, 2013 to December 31, 2014 Issuance of common stock and Series A3 and A4 preferred stock under Sercurities Purchase Agreement Issuance of common stock upon conversion of preferred stock Issuance of common stock under employees stock purchase plan Common stock issued to settle incentive compensation obligations
2014-12-31
2014-07-24 794.43 0.40 定期报告 2014-07-14
2014-07-24 675.90 0.64 定期报告 2014-06-30
2014-02-24 594.56 未披露
更多>>
from December 31, 2012 to December 31, 2013 Issuance of common stock and preferred stock under Securities Purchase Agreement Issuance of common stock upon conversion of preferred stock Issuance of common stock upon exercise of warrants Issuance of common stock under employee stock purchase plan Common stock issued to settle incentive compensation obligations
2013-12-31
2013-10-24 298.61 未披露 定期报告 2013-10-17
2013-10-24 283.61 0.37 定期报告 2013-09-30
2013-07-26 263.61 未披露 定期报告 2013-07-18
2013-07-26 250.51 0.44 定期报告 2013-06-30
2013-06-17 250.65 未披露 定期报告 2013-06-10
2013-04-25 226.02 未披露 定期报告 2013-03-31
2013-02-25 214.09 未披露
更多>>
From December 31, 2011 to December 31, 2012 Issuance of common stock and warrants in public offering Issuance of common stock on redemption of warrants Issuance of common stock under employee stock purchase plan Other issuances of stock from option plan The number of stock was adjusted due to 1:6 reverse stock split implemented on February 15, 2013
2012-12-31
2012-08-03 1282.50 未披露 定期报告 2012-06-30
2012-04-24 1278.63 未披露 定期报告 2012-03-31
2012-02-24 1243.09 未披露 定期报告 2012-02-15
2012-02-24 390.43 未披露
更多>>
from December 31, 2010 to December 31, 2011 Other issuances of stock from option plan Issuance of common stock under employee stock purchase plan On September 1, 2011, the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware, to effect a 1-for-6 reverse stock split of its common stock, or the Reverse Stock Split.
2011-12-31
2011-10-27 388.81 未披露
更多>>
on September 1, 2011, the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware, to effect a 1-for-6 reverse stock split of its common stock, or the Reverse Stock Split.
2011-09-30
2011-07-28 2334.41 未披露 定期报告 2011-06-30
2011-04-28 2329.96 未披露 定期报告 2011-03-31
2011-03-07 2319.75 未披露
更多>>
from dec 31 2009 to dec 31 2010 Issuance of stock from stock option plans Issuance of common stock under employee stock purchase plan Other issuances of stock from our option plan
2010-12-31
2010-08-10 2309.83 未披露 定期报告 2010-06-30
2010-05-14 2303.81 未披露 定期报告 2010-03-31
From December 31,2022 to December 31,2023 Issuance of common stock under at the market offering Issuance of common stock under employee stock purchase plan Vesting of restricted stock under equity plan
NeuroMetrix, Inc. announced that it will effect a one-for-eight reverse split of its common stock, effective at 5:00 pm on November 21, 2023 (the “Effective Time”).
From December 31, 2022 to March 31, 2023 Vesting of restricted stock under option plan
From December 31, 2021 to December 31, 2022 Issuance of common stock under employee stock purchase plan Issuance of common stock under at the market offering Issuance of common stock to settle compensation obligation Vesting of restricted stock under option plan
From June 30, 2022 to September 30, 2022 Vesting of restricted stock under equity plan
From March 31, 2022 to June 30, 2022 Issuance of common stock under employee stock purchase plan Issuance of common stock to settle compensation obligation Vesting of restricted stock under equity plan
From December 31, 2021 to March 31, 2022 Issuance of common stock under at the market offering Vesting of restricted stock under option plan
From December 31, 2020 to December 31, 2021 Issuance of common stock under at the market offering Issuance of common stock upon exercise of stock options Issuance of common stock under employee stock purchase plan Vesting of restricted stock under option plan
From June 30, 2021 to September 30, 2021 Issuance of common stock under at the market offering Issuance of common stock upon exercise of stock options Vesting of restricted stock under option plan
From March 31, 2021 to June 30, 2021 Issuance of common stock under at the market offering Issuance of common stock under employee stock purchase plan Vesting of restricted stock under option plan
From December 31,2019 to December 31,2020 Issuance of common stock under at the market offering Issuance of common stock to settle compensation obligations Issuance of common stock under employee stock purchase plan
From March 31, 2020 to June 30, 2020 Issuance of common stock under at the market offering Issuance of common stock under employee stock purchase plan
From December 31, 2019 to March 31, 2020 Issuance of common stock under at the market offering Common stock issued to settle compensation obligations
from December 31, 2018 to December 31, 2019 Issuance of common stock upon conversion of preferred stock Issuance of common stock under employee stock purchase plan
Trading of the Company's common stock on the NASDAQ Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Tuesday, November 19, 2019, under new CUSIP number 641255807. Trading of the Company's listed warrants to purchase common stock on the Nasdaq Capital Market will also continue, on a split-adjusted basis, with the opening of the markets on Tuesday, November 19, 2019 under new CUSIP number 641255211. Shares of the Company's common stock and the Company's listed warrants to purchase common stock will continue to trade under the symbols "NURO" and "NUROW". Immediately subsequent to the reverse stock split, there will be approximately 978,175 shares of the Company's common shares issued and outstanding.
From December 31, 2018 To June 30, 2019 Issuance of common stock upon conversion of preferred stock Issuance of common stock under employee stock purchase plan
From December 31, 2018 to March 31, 2019 Issuance of common stock upon conversion of preferred stock
From December 31, 2017 to December 31, 2018 Issuance of common stock upon conversion of preferred stock Common stock issued to settle employee incentive compensation obligations Issuance of common stock under employees stock purchase plan
from December 31, 2016 to December 31, 2017 Issuance of Series E preferred stock and warrants and repricing other holdings under purchase agreement Issuance of Series F preferred stock and repurchase of certain warrants under purchase agreement Issuance of common stock upon conversion of preferred stock Issuance of common stock under employees stock purchase plan Issuance of common stock in exchange for warrants
NeuroMetrix, Inc.today announced a one-for-eight reverse split of its common stock effective as of Thursday, May 11, 2017. The shares underlying the Company's outstanding options and warrants will also be adjusted accordingly.Trading of the Company's listed warrants to purchase common stock on the NASDAQ Capital Market will also continue, on a split-adjusted basis, with the opening of the markets on Friday, May 12, 2017, under new CUSIP number 641255195.
from December 31, 2015 to December 31, 2016 Issuance of Series D preferred stock and warrants and redemption of Series C preferred stock under purchase agreement Issuance of common stock upon conversion of preferred stock Issuance of common stock under employees stock purchase plan Common stock issued to settle incentive compensation obligations
From December 31, 2014 to December 31, 2015 Issuance of Series B preferred stock and warrants under underwritten public offering Redemption of Series A-4 preferred stock Issuance of Series C preferred stock and warrants and redemption of Series B preferred stock under purchase agreement Issuance of common stock upon conversion of preferred stock Issuance of common stock under employees stock purchase plan Common stock issued to settle incentive compensation obligations As previously disclosed on a Current Report on Form 8-K filed on December 1, 2015, we filed a Certificate of Amendment to our Restated Certificate of Incorporation to effect a 1-for-4 reverse stock split of our common stock as of December 1, 2015
As previously disclosed on a Current Report on Form 8-K filed on December 1, 2015, we filed a Certificate of Amendment to our Restated Certificate of Incorporation to effect a 1-for-4 reverse stock split of our common stock as of December 1, 2015
from December 31, 2013 to December 31, 2014 Issuance of common stock and Series A3 and A4 preferred stock under Sercurities Purchase Agreement Issuance of common stock upon conversion of preferred stock Issuance of common stock under employees stock purchase plan Common stock issued to settle incentive compensation obligations
from December 31, 2012 to December 31, 2013 Issuance of common stock and preferred stock under Securities Purchase Agreement Issuance of common stock upon conversion of preferred stock Issuance of common stock upon exercise of warrants Issuance of common stock under employee stock purchase plan Common stock issued to settle incentive compensation obligations
From December 31, 2011 to December 31, 2012 Issuance of common stock and warrants in public offering Issuance of common stock on redemption of warrants Issuance of common stock under employee stock purchase plan Other issuances of stock from option plan The number of stock was adjusted due to 1:6 reverse stock split implemented on February 15, 2013
from December 31, 2010 to December 31, 2011 Other issuances of stock from option plan Issuance of common stock under employee stock purchase plan On September 1, 2011, the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware, to effect a 1-for-6 reverse stock split of its common stock, or the Reverse Stock Split.
on September 1, 2011, the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware, to effect a 1-for-6 reverse stock split of its common stock, or the Reverse Stock Split.
from dec 31 2009 to dec 31 2010 Issuance of stock from stock option plans Issuance of common stock under employee stock purchase plan Other issuances of stock from our option plan